Infection and Medication-related Osteonecrosis of the Jaw
Authors:
- 20 February 2015
- journal article
- review article
- Published by SAGE Publications in Journal of Dental Research
- Vol. 94 (4) , 534-539
Abstract
Medication-related osteonecrosis of the jaw (MRONJ), although initially believed to be exclusively associated with bisphosphonates, has been implicated in recent reports with additional drugs, especially the bone antiresorptive denosumab. The pathophysiology has not been fully elucidated, and no causal association between bone antiresorptive regimens and MRONJ has yet been established. However, reduced bone turnover and infection, an almost universal finding, are thought to be central to the pathogenesis of MRONJ. Both bisphosphonates and denosumab, through different pathways of action, significantly reduce the rate of bone turnover and potentially reduce the efficacy of the host defense against infection. Recent evidence questions the simplified etiology of low bone turnover causing MRONJ and offers evidence on the prominent role of infection instead. The management of MRONJ remains a significant clinical challenge, with little progress having been made on treatment. The aim of this article is to explore the current theories on the etiology of MRONJ and to emphasize the importance of infection in the development of this devastating pathology.Keywords
This publication has 49 references indexed in Scilit:
- Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient MicePLOS ONE, 2013
- Bisphosphonate‐induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed boneJournal of Oral Pathology & Medicine, 2012
- Bone-bound bisphosphonate inhibits growth of adjacent non-bone cellsBone, 2011
- Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jawBritish Journal of Oral and Maxillofacial Surgery, 2011
- Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in ratsJournal of Bone and Mineral Research, 2010
- Development of Monocytes, Macrophages, and Dendritic CellsScience, 2010
- Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitroClinical Oral Investigations, 2009
- Expression of receptor activator of nuclear factor‐κB ligand by B cells in response to oral bacteriaOral Microbiology and Immunology, 2009
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous BisphosphonatesJournal of Bone and Mineral Research, 2008
- Osteoclast differentiation and activationNature, 2003